Skip to main content

Table 2 The safety of PRV GDFS-delgI/gE/US9/US2 in 5–7 days-old suckling piglets

From: Construction of a quadruple gene-deleted vaccine confers complete protective immunity against emerging PRV variant challenge in piglets

Groups

Doses TCID50/ml

Amounts

Temperature (≥ 40.0 °C)

Clinical signs

DMEM

1 ml

5

0/5

0/5

Bartha K61

105

5

0/5

0/5

GDFS-delgI/gE/US9/US2

105

5

0/5

0/5

106

5

0/5

0/5